Mitochondrial / energy

MOTS-c

Mitochondrial-derived peptide

Thin — one-source, early research
Based on expert consensus from publicly available videos plus public FDA/regulatory status — not medical advice. Peptides are prescription territory; consult a physician before using anything here.

The Verdict

A mitochondrial peptide with genuine scientific interest, but in our corpus it's a single-source, early-research topic — promising biology, not a proven protocol.

The Evidence

FDA / Legal Status

Not FDA-approved

Human Evidence

Framed as optimizing mitochondrial energy production; covered by a single clinician guest in our corpus

Sport / Doping

Check sport status

Safety Flags

  • Very limited human data; one-source coverage
  • Gray-market sourcing risk

Who Covers It

Mark Hyman
Mark Hyman

Other experts in the panel had no substantive coverage of this peptide — we don't guess their position.

Want the deep dive on MOTS-c?

This grade is free. Pro unlocks chat with the full expert dataset — ask about dosing, stacks, sourcing, and the exact citations behind every claim.

Cancel anytime

Go Deeper